bretylium has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 3 studies
bretylium: RN given refers to parent cpd
bretylium : A quaternary ammonium cation having 2-bromobenzyl, ethyl and two methyl groups attached to the nitrogen. It blocks noradrenaline release from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibrillation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Within 97 +/- 163 s, aconitine induced ventricular tachycardia (VT) with a mean cycle length 268 +/- 37 ms, which accelerated before converting to VF." | 1.31 | Action potential duration restitution and ventricular fibrillation due to rapid focal excitation. ( Chen, PS; Garfinkel, A; Karagueuzian, HS; Lee, MH; Lin, SF; Ohara, T; Qu, Z; Swissa, M; Weiss, JN, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lang, E | 1 |
| Al Raisi, M | 1 |
| Olshansky, B | 1 |
| Swissa, M | 1 |
| Qu, Z | 1 |
| Ohara, T | 1 |
| Lee, MH | 1 |
| Lin, SF | 1 |
| Garfinkel, A | 1 |
| Karagueuzian, HS | 1 |
| Weiss, JN | 1 |
| Chen, PS | 1 |
1 review available for bretylium and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Ventricular tachyarrhythmias (out of hospital cardiac arrests).
Topics: Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Electric Countershock; Humans; Lidocaine; T | 2006 |
2 other studies available for bretylium and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Ventricular arrhythmias and the use of antiarrhythmic drugs after cardiovascular surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiovascular Surgical Procedures; Clinica | 1998 |
Action potential duration restitution and ventricular fibrillation due to rapid focal excitation.
Topics: Aconitine; Action Potentials; Animals; Anti-Arrhythmia Agents; Bretylium Compounds; Computer Simulat | 2002 |